UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051419
Receipt number R000058654
Scientific Title The Study for objective assessment methods of daily "Vitality": Focus on muscle strength
Date of disclosure of the study information 2023/07/01
Last modified on 2023/06/22 22:07:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Study for objective assessment methods of daily "Vitality"

Acronym

Assessment methods of daily "Vitality"

Scientific Title

The Study for objective assessment methods of daily "Vitality": Focus on muscle strength

Scientific Title:Acronym

The Study for objective assessment methods of daily "Vitality": Focus on muscle strength

Region

Japan


Condition

Condition

Vitality

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the relationship between the daily "vitality" and muscular strength or physiological biomarker

Basic objectives2

Others

Basic objectives -Others

To clarify the relationship between the daily "vitality" and muscular strength or physiological biomarker

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle strength

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Residents in Kusatsu-city
Students in Ritsumeikan university

Key exclusion criteria

1) Patients with serious diseases who are prohibited from exercising
2) Patients with arrhythmia
3) Patients with mental disorder such as depression

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Haruka
Middle name
Last name Murakami

Organization

Ritsumeikan University

Division name

Faculty of Sport and Health Science

Zip code

525-8577

Address

1-1-1 Nojihigashi, Kusatsu, Shiga

TEL

077-561-2890

Email

haruka-m@fc.ritsumei.ac.jp


Public contact

Name of contact person

1st name Haruka
Middle name
Last name Murakami

Organization

Ritsumeikan University

Division name

Faculty of Sport and Health Science

Zip code

525-8577

Address

1-1-1 Nojihigashi, Kusatsu, Shiga

TEL

077-561-2890

Homepage URL


Email

haruka-m@fc.ritsumei.ac.jp


Sponsor or person

Institute

Ritsumeikan University

Institute

Department

Personal name



Funding Source

Organization

Kusatsu-city
Ritsumeikan University

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Board for Medical and Health Research Involving Human Subjects

Address

1-1-1 Nojihigashi, Kusatsu, Shiga

Tel

077-599-4175

Email

b-rinri@st.ritsumei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 20 Day

Date of IRB

2023 Year 04 Month 21 Day

Anticipated trial start date

2023 Year 07 Month 05 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Exposures: daily lifestyle including physical activity, diet and sleep.
Outcome: day-to-day physiological and psychological conditions.


Management information

Registered date

2023 Year 06 Month 22 Day

Last modified on

2023 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058654


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name